Revisiting the "New" Inflammatory Toxicities of Adeno-Associated Virus Vectors.
暂无分享，去创建一个
[1] James M. Wilson,et al. Toxicology Study of Intra-Cisterna Magna Adeno-Associated Virus 9 Expressing Iduronate-2-Sulfatase in Rhesus Macaques , 2018, Molecular therapy. Methods & clinical development.
[2] James M. Wilson,et al. Toxicology Study of Intra-Cisterna Magna Adeno-Associated Virus 9 Expressing Human Alpha-L-Iduronidase in Rhesus Macaques , 2018, Molecular therapy. Methods & clinical development.
[3] HindererChristian,et al. Severe Toxicity in Nonhuman Primates and Piglets Following High-Dose Intravenous Administration of an Adeno-Associated Virus Vector Expressing Human SMN , 2018 .
[4] J. ByrneBarry,et al. Safety of Intradiaphragmatic Delivery of Adeno-Associated Virus-Mediated Alpha-Glucosidase (rAAV1-CMV-hGAA) Gene Therapy in Children Affected by Pompe Disease , 2017 .
[5] Thomas Ferkol,et al. Repeated aerosolized AAV-CFTR for treatment of cystic fibrosis: a randomized placebo-controlled phase 2B trial. , 2007, Human gene therapy.
[6] Marcela V Maus,et al. CD8+ T-cell responses to adeno-associated virus capsid in humans , 2007, Nature Medicine.
[7] T. Flotte,et al. Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector. , 1993, Proceedings of the National Academy of Sciences of the United States of America.